Probiotic agents in critically ill patients

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Probiotics are living organisms which, when ingested in sufficient quantities, confer health benefits upon their host. In this era of increasing antimicrobial resistance, early probiotic studies describing reduced rates of nosocomial infections garnered significant interest, particularly from clinical investigators studying intensive care unit outcomes. Although our current knowledge base is fragmented and limited by various methodologic issues, metaanalysis has been a powerful tool to combine studies and more rigorously assess probiotics’ efficacy in various disease states. The resulting reports suggest that probiotics may reduce overall infection rates – including ventilatorassociated pneumonia and Clostridium difficile infections – in critically ill patients. However, definitive conclusions remain elusive, and rigorous multicenter trials are needed to confirm or refute the findings of these meta-analyses.

Original languageEnglish (US)
Title of host publicationDiet and Nutrition in Critical Care
PublisherSpringer New York
Pages1017-1024
Number of pages8
ISBN (Electronic)9781461478362
ISBN (Print)9781461478379
DOIs
StatePublished - Jan 1 2015

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Probiotic agents in critically ill patients'. Together they form a unique fingerprint.

  • Cite this

    Morrow, L. L., Naveed, A., & Malesker, M. A. (2015). Probiotic agents in critically ill patients. In Diet and Nutrition in Critical Care (pp. 1017-1024). Springer New York. https://doi.org/10.1007/978-1-4614-7836-2_77